264 related articles for article (PubMed ID: 32770504)
21. The subcellular sites of sphingomyelin synthesis in BHK cells.
Miro Obradors MJ; Sillence D; Howitt S; Allan D
Biochim Biophys Acta; 1997 Oct; 1359(1):1-12. PubMed ID: 9398080
[TBL] [Abstract][Full Text] [Related]
22. Segregation of glucosylceramide and sphingomyelin occurs in the apical to basolateral transcytotic route in HepG2 cells.
van IJzendoorn SC; Zegers MM; Kok JW; Hoekstra D
J Cell Biol; 1997 Apr; 137(2):347-57. PubMed ID: 9128247
[TBL] [Abstract][Full Text] [Related]
23. Keratinocytes rapidly readjust ceramide-sphingomyelin homeostasis and contain a phosphatidylcholine-sphingomyelin transacylase.
Wanner R; Peiser M; Wittig B
J Invest Dermatol; 2004 Mar; 122(3):773-82. PubMed ID: 15086565
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane.
Hackstadt T; Rockey DD; Heinzen RA; Scidmore MA
EMBO J; 1996 Mar; 15(5):964-77. PubMed ID: 8605892
[TBL] [Abstract][Full Text] [Related]
25. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
Allan D
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519
[TBL] [Abstract][Full Text] [Related]
26. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
Breiden B; Sandhoff K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor.
Andrieu N; Salvayre R; Levade T
Eur J Biochem; 1996 Mar; 236(2):738-45. PubMed ID: 8612652
[TBL] [Abstract][Full Text] [Related]
28. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.
Gupta VR; Patel HK; Kostolansky SS; Ballivian RA; Eichberg J; Blanke SR
PLoS Pathog; 2008 May; 4(5):e1000073. PubMed ID: 18497859
[TBL] [Abstract][Full Text] [Related]
29. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
[TBL] [Abstract][Full Text] [Related]
30. Ceramide-enriched membrane domains.
Bollinger CR; Teichgräber V; Gulbins E
Biochim Biophys Acta; 2005 Dec; 1746(3):284-94. PubMed ID: 16226325
[TBL] [Abstract][Full Text] [Related]
31. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?
Cremesti AE; Goni FM; Kolesnick R
FEBS Lett; 2002 Oct; 531(1):47-53. PubMed ID: 12401201
[TBL] [Abstract][Full Text] [Related]
32. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway.
Mendez AJ; Lin G; Wade DP; Lawn RM; Oram JF
J Biol Chem; 2001 Feb; 276(5):3158-66. PubMed ID: 11073951
[TBL] [Abstract][Full Text] [Related]
33. Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy.
Albi E; Peloso I; Magni MV
Biochem Biophys Res Commun; 1999 Sep; 262(3):692-5. PubMed ID: 10471387
[TBL] [Abstract][Full Text] [Related]
34. Intracellular lipid droplets contain dynamic pools of sphingomyelin: ADRP binds phospholipids with high affinity.
McIntosh AL; Storey SM; Atshaves BP
Lipids; 2010 Jun; 45(6):465-77. PubMed ID: 20473576
[TBL] [Abstract][Full Text] [Related]
35. Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism.
Pütz U; Schwarzmann G
Eur J Cell Biol; 1995 Oct; 68(2):113-21. PubMed ID: 8575458
[TBL] [Abstract][Full Text] [Related]
36. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
[TBL] [Abstract][Full Text] [Related]
38. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux.
Leventhal AR; Chen W; Tall AR; Tabas I
J Biol Chem; 2001 Nov; 276(48):44976-83. PubMed ID: 11579092
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelinase-induced phase transformations: causing morphology switches and multiple-time-domain ceramide generation in model raft membranes.
Chao L; Gast AP; Hatton TA; Jensen KF
Langmuir; 2010 Jan; 26(1):344-56. PubMed ID: 19863058
[TBL] [Abstract][Full Text] [Related]
40. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity.
van Helvoort A; Giudici ML; Thielemans M; van Meer G
J Cell Sci; 1997 Jan; 110 ( Pt 1)():75-83. PubMed ID: 9010786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
